ArticleInternational journal of retina and vitreous2025
Scleral buckling as a standalone surgery in the era of pars plana vitrectomy: a 10-year retrospective cohort study.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality of Life Following Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScleral buckling (SB) is an established treatment for rhegmatogenous retinal detachment (RRD). Once the gold standard for RRD repair, SB became less performed with the rise of pars plana vitrectomy (PPV). This retrospective interventional cohort study aims to provide 10 years of real-world data on SB surgical outcomes in a Canadian tertiary eye center.
methodsPatients undergoing primary SB surgery at the CHU de Québec between January 2014 and December 2023 for primary RRD with at least 3 months of postoperative follow-up were included. Multiple linear and logistic regression models were developed to identify variables associated with final BCVA and single surgery anatomical success (SSAS).
resultsA total of 187 phakic patients undergoing primary SB surgery with a median [Q1, Q3] follow-up (FU) of 23.0 [11.0, 38.9] months were included. Females constituted 56.1% (n = 105) of the cohort with a median age at surgery of 36.9 [28.6, 47.0] years. Most patients did not have a preoperative posterior vitreous detachment (n = 161, 86.1%). Macula status was on for 109 (58.3%), off for 46 (24.6%), and split for 32 (17.1%) patients. Median RRD extent was of 4.0 [3.0, 5.0] clock hours, with the preoperative number of retinal breaks being of 2.0 [1.0, 3.0]. Inferior RRD associated with inferior breaks was present in 101 (54.0%) eyes. SSAS was achieved in 169 (90.4%) cases, with 184 (98.4%) patients achieving retinal reattachment at last follow-up. BCVA progressed from baseline median values of 0.14 [0.00, 0.40] logMAR, improving by 12 months (0.12 [0.02, 0.30], p = 0.004) and by final follow-up (0.10 [0.00, 0.28], p < 0.001). Male sex was a negative predictor of SSAS (p = 0.008), while SF6 gas tamponade was a positive predictor (p = 0.035). Chronicity of RRD (p = 0.012) and worse preoperative BCVA (p < 0.001) were associated with worse final BCVA.
conclusionsThe use of primary SB as a standalone surgery continues to be a safe and effective technique for RRD repair, specifically in young phakic patients with no PVD; or when PPV may not be the preferred option to preserve lens state and avoid iatrogenic retinal breaks, two well-documented complications of vitrectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.